表紙
市場調査レポート

先進ドラッグデリバリーシステム (DDS) :技術および世界市場

Global Markets and Technologies for Advanced Drug Delivery Systems

発行 BCC Research 商品コード 219299
出版日 ページ情報 英文 196 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
先進ドラッグデリバリーシステム (DDS) :技術および世界市場 Global Markets and Technologies for Advanced Drug Delivery Systems
出版日: 2016年03月24日 ページ情報: 英文 196 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の先進ドラッグデリバリー市場規模は、2015年の1,788億米ドルから2020年までに約2,273億米ドルへ、4.9%のCAGR (年間複合成長率) で拡大すると予測されています。

当レポートでは、世界のドラッグデリバリー市場の現状と将来動向について調査し、エンドユーザー・各アプリケーション別の市場分析、市場データ・CAGR予測を含む市場動向の分析、市場の現況、抑制要因、革新、および将来のニーズに関する議論、ドラッグデリバリーの各分類の評価、規制環境・関連技術の分析、および主要企業のプロファイルなどをまとめ、お届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 先進ドラッグデリバリー市場の発展・ダイナミクス
  • 先進ドラッグデリバリー産業のライフステージ/成長ステージ
  • マルチリリース技術市場
  • 世界の先進ドラッグデリバリー市場分析
  • 競合状況
  • 特許分析

第4章 先進ドラッグデリバリー技術/システム市場

  • 先進短時間作用型技術
  • 放出調節ドラッグデリバリー
    • 標的指向ドラッグデリバリー技術
    • 長時間作用型
    • 持続性放出型・制御放出型 (徐放型) ドラッグデリバリーシステム
    • 遅延放出型・パルス放出型ドラッグデリバリー技術

第5章 市場:投与経路別

  • 経口ドラッグデリバリー市場
  • 非経口/注射剤ドラッグデリバリー市場
  • 局所ドラッグデリバリー市場
  • 経皮ドラッグデリバリー市場
  • 経粘膜的ドラッグデリバリー市場
  • インプラントドラッグデリバリー市場

第6章 市場:ドラッグデリバリー媒体/キャリア別

  • リポソーム
    • 市場分析・将来の展望
    • ミセル・デンドリマー
    • ポリマー
  • ナノキャリア・ナノ粒子
  • 微小粒子/ミクロスフェア
  • モノクロナール抗体
  • プロドラッグ
  • その他

第7章 市場:アプリケーション別

  • 心血管
  • 腫瘍
  • 消化器疾患
  • 泌尿器
  • 糖尿病
  • 皮膚科
  • 中枢神経系
  • 呼吸器ドラッグデリバリーシステム
  • 炎症性疾患・アレルギー
  • 眼科
  • ウィルス・細菌性疾患
  • ホルモン代替療法・婦人科
  • その他の治療分類

第8章 競合発展

  • イントロダクション

第9章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他 (ROW)

第10章 付録

第11章 企業プロファイル

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHM006K

REPORT HIGHLIGHTS

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.

This report provides:

  • An overview of the global market for drug delivery systems, including the market as seen by end users of different applications
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Discussion of the current state, setbacks, innovations, and the future needs of the market
  • Examination of the different categories of drug delivery, broken down by market shares of the leading manufacturers and/or suppliers, as well as acquisitions, mergers, and alliances by companies and global organizations
  • Analyses of the regulatory environment, and the technology involved, including the latest trends and developments
  • Profiles of major players in the industry

SCOPE OF REPORT

The report's scope includes the following:

  • Key market analysis
  • Market dynamics (drivers and restraints)
  • Market estimation for the forecasted period (2015 through 2020)
  • Competitive developments and landscape
  • Regional analysis
  • Profiles of key market players
  • Patents

ANALYST'S CREDENTIALS

Himani S. Wadhwa has more than five years of experience in healthcare, biotechnology and life sciences business research and consulting. She has commissioned several syndicated market and business reports in the life sciences domain, and has been tracking several healthcare sectors over the last seven years.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • INFORMATION SOURCES AND METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • ADVANCED DRUG DELIVERY MARKET EVOLUTION AND DYNAMICS
  • ADVANCED DRUG DELIVERY INDUSTRY LIFE/GROWTH STAGES
    • FIRST GENERATION - CONTROLLED/MODIFIED RELEASE TECHNOLOGIES
    • SECOND GENERATION - NEW WAVE OF ADVANCED DRUG DELIVERY TECHNOLOGIES WITH EMERGENCE OF SMART DRUG DELIVERY
    • THIRD GENERATION - NEW FRONTIER OF ADVANCED DRUG DELIVERY WITH SIGNIFICANT ADVANCES IN MODIFIED DELIVERY SYSTEMS
  • MULTIPLE-RELEASE TECHNOLOGY MARKET
    • FIXED DOSE COMBINATION MULTIPLE RELEASE TECHNOLOGY -- MAJOR PHASE OF NEXT GENERATION ADVANCED DRUG DELIVERY MARKET.
    • MARKET DRIVERS AND RESTRAINTS
  • GLOBAL ADVANCED DRUG DELIVERY MARKET ANALYSIS
    • FIGURE 1: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%)
    • FIGURE 2: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%)
    • FIGURE 3: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%)
  • COMPETITIVE LANDSCAPE
  • PATENT ANALYSIS
    • FIGURE 4: PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%)

CHAPTER 4 - ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS MARKET

  • TABLE 1: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TABLE 2: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
  • FIGURE 5: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%)
  • ADVANCED IMMEDIATE-RELEASE TECHNOLOGY
    • DRIVERS AND RESTRAINTS
      • TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • MODIFIED DRUG DELIVERY
      • TABLE 4: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 5: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TARGETED DRUG DELIVERY TECHNOLOGY
      • Drivers and Restraints
      • Market Analysis
      • Future Outlook
      • Market Players
        • TABLE 6: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, THROUGH 2020 ($ MILLIONS)
        • TABLE 7: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
        • TABLE 8: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • EXTENDED DRUG RELEASE
      • TABLE 9: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, THROUGH 2020 ($ MILLIONS)
      • TABLE 10: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
      • TABLE 11: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
      • TABLE 12: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • SUSTAINED AND CONTROLLED RELEASE DRUG DELIVERY SYSTEMS
      • Drivers and Restraints
      • Market Analysis and Future Outlook
      • Market Players
        • TABLE 13: GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
        • TABLE 14: GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • DELAYED RELEASE AND PULSATILE RELEASE DRUG DELIVERY TECHNOLOGY
      • Market Analysis
      • Drivers and Restraints
      • Market Players
        • TABLE 15: GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
        • TABLE 16: GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 5 - MARKET BY ROUTE OF ADMINISTRATION

  • TABLE 17: GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
  • FIGURE 6: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%)
  • ORAL DRUG DELIVERY MARKET
    • MARKET DRIVERS AND RESTRAINTS/CHALLENGES
    • MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE FACTORS
      • TABLE 18: EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS) TECHNOLOGIES AND PRODUCTS
      • Opportunities/Future Outlook
    • MARKET PLAYERS
      • TABLE 19: GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • PARENTERAL/INJECTABLE DRUG DELIVERY MARKET
    • DRIVERS AND RESTRAINTS
    • MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE FACTORS
    • FUTURE OUTLOOK/OPPORTUNITIES
    • MARKET PLAYERS
      • TABLE 20: GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TOPICAL DRUG DELIVERY MARKET
    • MARKET ANALYSIS - DEVELOPMENTS AND INNOVATIONS
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET PLAYERS
      • TABLE 21: GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TRANSDERMAL DRUG DELIVERY
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET ANALYSIS - PRODUCT EXAMPLES, INNOVATION AND FUTURE OUTLOOK
    • FUTURE OUTLOOK/OPPORTUNITIES
    • MARKET PLAYERS
      • TABLE 22: GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TRANSMUCOSAL MARKET
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET PLAYERS
      • TABLE 23: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 24: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • NASAL AND PULMONARY MARKET
      • Market Drivers and Analysis
        • TABLE 25: GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • OCULAR DRUG DELIVERY
      • Market Analysis
        • TABLE 26: GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • ORAL - BUCCAL DRUG DELIVERY
      • Market Analysis
        • TABLE 27: GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • VAGINAL DRUG DELIVERY
      • TABLE 28: GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • RECTAL DRUG DELIVERY
      • TABLE 29: GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • IMPLANTS DRUG DELIVERY
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET ANALYSIS AND FUTURE OUTLOOK
    • MARKET PLAYERS
      • TABLE 30: GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • CONTRACEPTIVE DEVICES
      • TABLE 31: GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - MARKET BY DRUG DELIVERY VEHICLES/CARRIERS

  • TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
  • FIGURE 7: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%)
  • LIPOSOMES
    • MARKET ANALYSIS AND FUTURE OUTLOOK
      • TABLE 33: GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • POLYMERIC THERAPEUTICS
      • TABLE 34: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 35: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • MICELLES AND DENDRIMERS
      • Polymeric Micelles (Micelles)
      • Market Analysis
        • TABLE 36: GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
      • Dendrimers
      • Market Analysis
        • TABLE 37: GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • POLYMERS (POLYMERIC DRUG DELIVERY)
      • Market Analysis
      • Reservoir-based Systems
      • Monolithic Matrix Systems
      • Polymer-drug Conjugate Systems
        • TABLE 38: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
        • TABLE 39: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS)
    • NANOCARRIERS/NANOPARTICLES
      • TABLE 40: GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • MICROPARTICLES/MICROSPHERES
      • TABLE 41: GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • MONOCLONAL ANTIBODIES (MABS)
      • TABLE 42: GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • PRODRUGS
      • TABLE 43: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 44: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • OTHERS
      • TABLE 45: GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 7 - MARKET BY APPLICATIONS

  • TABLE 46: GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • FIGURE 8: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%)
  • CARDIOVASCULAR
    • TABLE 47: GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • ONCOLOGY MARKET
    • TABLE 48: GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • GASTROINTESTINAL DISORDERS
    • TABLE 49: GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • UROLOGY
    • TABLE 50: GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • DIABETES
    • TABLE 51: GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • DERMATOLOGY
    • TABLE 52: GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • CENTRAL NERVOUS SYSTEM
    • TABLE 53: GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • RESPIRATORY DRUG DELIVERY SYSTEMS
    • TABLE 54: GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • INFLAMMATORY DISEASES AND ALLERGIES
    • TABLE 55: GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • OPHTHALMOLOGY
    • TABLE 56: GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • VIRAL AND BACTERIAL DISEASES
    • TABLE 57: GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • HORMONE REPLACEMENT THERAPY AND GYNECOLOGY
    • TABLE 58: GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • OTHER THERAPEUTIC CATEGORIES
    • TABLE 59: GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 8 - COMPETITIVE DEVELOPMENTS

  • INTRODUCTION
    • FIGURE 9: DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%)
    • TABLE 60: DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015
    • TABLE 61: DEVELOPMENTS -- COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013- DEC 2015
    • TABLE 62: DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015
    • TABLE 63: DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015

CHAPTER 9 - REGIONAL ANALYSIS

  • NORTH AMERICA
    • TABLE 64: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 65: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 66: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 67: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
  • EUROPE
    • TABLE 68: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 69: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 70: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 71: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 72: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 73: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 74: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 75: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
  • REST OF THE WORLD (ROW)
    • TABLE 76: ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 77: ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 78: ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 79: ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)

CHAPTER 10 APPENDIX

  • TABLE 80: LIST (EXAMPLES) OF PATENTS, 2015
  • TABLE 81: LIST (EXAMPLES) PATENTS, 2014

CHAPTER 11 - COMPANY PROFILES

  • 3M COMPANY
  • ABBOTT LABORATORIES
  • ALLERGAN PLC
  • AKELA PHARMA INC.
  • ALCON INC. (NOVARTIS COMPANY)
  • AMGEN INC.
  • A.P. PHARMA/ HERON THERAPEUTICS, INC.
  • APTALIS PHARMA INC. /ADARE PHARMACEUTICALS
  • ALKERMES
  • ASTELLAS PHARMA INC.
  • ASTRAZENECA PLC
  • BAUSCH & LOMB
  • BAXTER INTERNATIONAL INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BIOGEN IDEC
  • BIOSANTE PHARMACEUTICALS INC.
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRISTOL-MYERS SQUIBB
  • CAPSUGEL
  • CATALENT
  • CELGENE CORP.
  • EISAI CO. LTD.
  • ELAN DRUG TECHNOLOGIES/PERRIGO COMPANY
  • ENZON PHARMACEUTICALS
  • ELIXIR MEDICAL CORP.
  • FLAMEL TECHNOLOGIES
  • GENENTECH INC.
  • GENEREX BIOTECHNOLOGY CORP.
  • GENZYME CORP.
  • GILEAD SCIENCES INC.
  • GLAXOSMITHKLINE PLC
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • ELI LILLY & IMCLONE SYSTEMS
  • JANSSEN BIOTECH INC.
  • JOHNSON & JOHNSON
  • KEMPHARM INC.
  • KYOTO MEDICAL PLANNING CO. LTD.
  • MANNKIND CORP.
  • MEDTRONIC
  • MERCK & CO.
  • MYLAN LABORATORIES INC.
  • NEKTAR THERAPEUTICS
  • NEWGEN BIOPHARMA
  • NOVARTIS AG
  • NOVAVAX INC.
  • NOVEN PHARMACEUTICALS INC.
  • PAR PHARMACEUTICAL COMPANIES INC.
  • PDL BIOPHARMA INC.
  • PFIZER INC.
  • ROCHE HOLDING AG
  • SANOFI SA
  • SKYEPHARMA
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • THERAJECT INC.
  • VALEANT PHARMACEUTICALS INTERNATIONAL INC.
  • XEL PHARMACEUTICALS INC.

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 2: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 3: GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 4: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 5: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 6: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, THROUGH 2020 ($ MILLIONS)
    • TABLE 7: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 8: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 9: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 12: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS) TECHNOLOGIES AND PRODUCTS
    • TABLE 19: GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 45: GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 46: GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 47: GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 48: GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 53: GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 54: GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 55: GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 56: GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 57: GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 58: GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 59: GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 60: DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015
    • TABLE 61: DEVELOPMENTS -- COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013- DEC 2015
    • TABLE 62: DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015
    • TABLE 63: DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015
    • TABLE 64: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 65: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 66: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 67: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 68: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 69: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 70: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 71: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 72: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 73: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 74: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 75: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 76: ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 77: ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 78: ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 79: ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 80: LIST (EXAMPLES) OF PATENTS, 2015
    • TABLE 81: LIST (EXAMPLES) PATENTS, 2014

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 1: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%)
    • FIGURE 2: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%)
    • FIGURE 3: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%)
    • FIGURE 4: PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%)
    • FIGURE 5: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%)
    • FIGURE 6: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%)
    • FIGURE 7: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%)
    • FIGURE 8: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%)
    • FIGURE 9: DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%)
Back to Top